Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trading Update & Subscription to Raise £1m

20th Dec 2010 07:00

RNS Number : 2216Y
Biofutures International plc
20 December 2010
 



 

Biofutures International plc

 

("Biofutures" or "the Company")

 

Trading Update and Subscription to raise £1m

 

 

Biofutures is pleased to announce that commissioning of the plant is occurring in line with previous announcements and the plant is expected to be operational by the end of the year. The Company also announces that it has raised £1m through the issue of equity.

 

Trading Update

 

The commissioning process has progressed in line with expectations and it is now moving into the final stages following which the plant will be fully operational. Major components such as the generator, steam boiler and air compressor unit have been tested. Hydrostatic testing has also taken place. Flushing of pipes, refinery electrical and instrumentation tests are scheduled to be completed within the week, following which air test and lop checks will commence. Crude palm oil will then be fed into the refining system to be refined into RBD Palm Oil followed by the contractual performance test. The Company expects the plant to be fully operational by the end of the year.

 

Once the plant is fully operational, the Company initially will carry out third-party contract refining. Refined palm oil is more stable and hence may be stored for longer than crude palm oil and the Company has expressions of interest from a number of mill owners who currently have insufficient or no refining capabilities.

 

The next step will be for the Company to progress to refining its own palm oil. The intention is to do this under agreed customer arrangements.

 

Details of the Subscription

 

The Company has raised £1m, gross of any expenses, through the subscription by an existing investor for 15,385,000 new ordinary shares (the "Subscription Shares") at 6.5p per share. As part of the subscription, the investor will also receive warrants over a further 15,385,000 new ordinary shares at an exercise price of 10p, exercisable in whole or in part at any time in the next twelve months.

 

The funds raised by the subscription, together with the Company's existing and unused facilities of approximately £4m, will be used to acquire the initial feedstock for the plant once it has become operational.

 

Application has been made for the admission to trading on AIM of the Subscription Shares and admission is expected to occur, and trading commence, at 8.00am on 22 December 2010. Once issued, the Subscription Shares will rank pari passu with the ordinary shares currently in issue.

 

Following the issue of the Subscription Shares, the Company will have an issued share capital of 166,445,000 ordinary shares of 1 p each.

 

For further information, please contact:

 

Biofutures International plc

Tel: + 6012 315 0626

Joe Wong, Chief Executive Officer

www.biofuturesplc.com

 

Daniel Stewart & Company plc

Tel: + 44 (0) 20 7776 6550

Oliver Rigby/Antony Legge (Nomad)

Colin Rowbury (Broker)

www.danielstewart.co.uk

 

 

The construction update and photographs are also available on the Company's web site at http://www.biofuturesplc.com/construction_update

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBRNRRRAUAAA

Related Shares:

Graphene Nanochem
FTSE 100 Latest
Value8,275.66
Change0.00